Purchases and Sales Made in Q2 2024 in Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV) during Q2 2024. The information is specifically focused on institutions that hold shares of Elevation Oncology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
4.64K+ 6.78% |
$10.9K - $24K
|
73K
$44.5K
|
|
Aug 14, 2024
Q2 2024
|
California State Teachers Retirement System
West Sacramento, CA |
BUY
|
- |
3.78KNew |
$8.88K - $19.5K
|
3.78K
$2.31K
|
|
Aug 12, 2024
Q2 2024
|
Amalgamated Bank
New York, NY |
BUY
|
- |
1.81KNew |
$4.24K - $9.33K
|
1.81K
$1.1K
|
|
Jul 25, 2024
Q2 2024
|
Simplex Trading, LLC
|
BUY
|
- |
147New |
$345 - $760
|
147
$89.7
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 13, 2024
Q2 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-1K- 33.33% |
$2.35K - $5.17K
|
2K
$1.22K
|
|
Aug 02, 2024
Q2 2024
|
Palumbo Wealth Management LLC
Great Neck, NY |
SELL
|
- |
-6.48K- 36.5% |
$15.2K - $33.5K
|
11.3K
$6.87K
|
|
Aug 14, 2024
Q2 2024
|
Prelude Capital Management, LLC
New York, NY |
SELL
|
- |
-8.31K- 8.28% |
$19.5K - $43K
|
92K
$56.1K
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-10.8K- 7.59% |
$25.4K - $56K
|
132K
$80.5K
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-28.8K- 36.48% |
$67.6K - $149K
|
50.1K
$30.6K
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-39.1K- 63.75% |
$91.9K - $202K
|
22.2K
$13.6K
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-46.9K- 8.52% |
$110K - $243K
|
504K
$308K
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-51.2K- 73.94% |
$120K - $265K
|
18.1K
$11K
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-61.6K- 25.11% |
$145K - $318K
|
184K
$112K
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-95K- 71.56% |
$223K - $491K
|
37.7K
$23K
|
|
Aug 14, 2024
Q2 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-100K- 23.26% |
$235K - $517K
|
330K
$201K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-107K- 87.09% |
$251K - $552K
|
15.8K
$9.66K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-108K- 90.38% |
$254K - $558K
|
11.5K
$7.01K
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-115K- 83.8% |
$270K - $594K
|
22.2K
$13.6K
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-171K- 21.71% |
$401K - $883K
|
616K
$376K
|
|
Aug 14, 2024
Q2 2024
|
Ven Bio Partners LLC
San Francisco, CA |
SELL
|
- |
-262K- 9.71% |
$615K - $1.35M
|
2.43M
$1.48M
|
|
Aug 14, 2024
Q2 2024
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-288K- 7.42% |
$677K - $1.49M
|
3.6M
$2.2M
|
|
Aug 14, 2024
Q2 2024
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
SELL
|
- |
-417K- 17.86% |
$979K - $2.15M
|
1.92M
$1.17M
|
|
Aug 14, 2024
Q2 2024
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-500K- 33.05% |
$1.18M - $2.59M
|
1.01M
$618K
|
|
Aug 14, 2024
Q2 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-572K- 18.72% |
$1.34M - $2.96M
|
2.48M
$1.52M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.53M- 97.44% |
$3.59M - $7.91M
|
40.1K
$24.5K
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.69M- 50.11% |
$3.97M - $8.73M
|
1.68M
$1.02M
|